Cargando…

Use of phosphate-binders and risk of infection-related and all-cause mortality in patients undergoing hemodialysis: The Q-Cohort Study

The use of phosphate (P)-binders allows hemodialysis patients to take in more protein and thus may maintain a good nutritional status. Protein-energy-malnutrition increases the risk of infection-related death. The association between use of P-binders and the relative risks of infection-related death...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Shunsuke, Tokumoto, Masanori, Taniguchi, Masatomo, Yoshida, Hisako, Arase, Hokuto, Tatsumoto, Narihito, Hirakata, Hideki, Kitazono, Takanari, Tsuruya, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065422/
https://www.ncbi.nlm.nih.gov/pubmed/30061632
http://dx.doi.org/10.1038/s41598-018-29757-0
_version_ 1783342865183670272
author Yamada, Shunsuke
Tokumoto, Masanori
Taniguchi, Masatomo
Yoshida, Hisako
Arase, Hokuto
Tatsumoto, Narihito
Hirakata, Hideki
Kitazono, Takanari
Tsuruya, Kazuhiko
author_facet Yamada, Shunsuke
Tokumoto, Masanori
Taniguchi, Masatomo
Yoshida, Hisako
Arase, Hokuto
Tatsumoto, Narihito
Hirakata, Hideki
Kitazono, Takanari
Tsuruya, Kazuhiko
author_sort Yamada, Shunsuke
collection PubMed
description The use of phosphate (P)-binders allows hemodialysis patients to take in more protein and thus may maintain a good nutritional status. Protein-energy-malnutrition increases the risk of infection-related death. The association between use of P-binders and the relative risks of infection-related death remains unknown in hemodialysis patients. A total of 2926 hemodialysis patients registered to the Q-Cohort Study was followed up for 4-years. The association between use of P-binders and the risks for infection-related and all-cause mortality were estimated by Cox proportional hazards risk model with multiple adjustments by conventional and propensity-score based approaches. During the follow-up period, 106 patients and 492 patients died of infection and any cause, respectively. Cox proportional hazards models with multivariable adjustments including nutritional confounders showed that the incidence of infection-related death was significantly lower in patients with P-binders use compared with those without (hazard ratio [95% confidence interval] for infection-related mortality 0.63 [0.40–0.99]). The results remained significant even after applying four different propensity score-based analyses. Notably, use of P-binders was associated with a lower risk of all-cause mortality. Further studies including randomized controlled clinical trials and observational studies analyzed by an instrumental variable model will provide more robust evidences for the associations observed in our study.
format Online
Article
Text
id pubmed-6065422
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-60654222018-08-06 Use of phosphate-binders and risk of infection-related and all-cause mortality in patients undergoing hemodialysis: The Q-Cohort Study Yamada, Shunsuke Tokumoto, Masanori Taniguchi, Masatomo Yoshida, Hisako Arase, Hokuto Tatsumoto, Narihito Hirakata, Hideki Kitazono, Takanari Tsuruya, Kazuhiko Sci Rep Article The use of phosphate (P)-binders allows hemodialysis patients to take in more protein and thus may maintain a good nutritional status. Protein-energy-malnutrition increases the risk of infection-related death. The association between use of P-binders and the relative risks of infection-related death remains unknown in hemodialysis patients. A total of 2926 hemodialysis patients registered to the Q-Cohort Study was followed up for 4-years. The association between use of P-binders and the risks for infection-related and all-cause mortality were estimated by Cox proportional hazards risk model with multiple adjustments by conventional and propensity-score based approaches. During the follow-up period, 106 patients and 492 patients died of infection and any cause, respectively. Cox proportional hazards models with multivariable adjustments including nutritional confounders showed that the incidence of infection-related death was significantly lower in patients with P-binders use compared with those without (hazard ratio [95% confidence interval] for infection-related mortality 0.63 [0.40–0.99]). The results remained significant even after applying four different propensity score-based analyses. Notably, use of P-binders was associated with a lower risk of all-cause mortality. Further studies including randomized controlled clinical trials and observational studies analyzed by an instrumental variable model will provide more robust evidences for the associations observed in our study. Nature Publishing Group UK 2018-07-30 /pmc/articles/PMC6065422/ /pubmed/30061632 http://dx.doi.org/10.1038/s41598-018-29757-0 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Yamada, Shunsuke
Tokumoto, Masanori
Taniguchi, Masatomo
Yoshida, Hisako
Arase, Hokuto
Tatsumoto, Narihito
Hirakata, Hideki
Kitazono, Takanari
Tsuruya, Kazuhiko
Use of phosphate-binders and risk of infection-related and all-cause mortality in patients undergoing hemodialysis: The Q-Cohort Study
title Use of phosphate-binders and risk of infection-related and all-cause mortality in patients undergoing hemodialysis: The Q-Cohort Study
title_full Use of phosphate-binders and risk of infection-related and all-cause mortality in patients undergoing hemodialysis: The Q-Cohort Study
title_fullStr Use of phosphate-binders and risk of infection-related and all-cause mortality in patients undergoing hemodialysis: The Q-Cohort Study
title_full_unstemmed Use of phosphate-binders and risk of infection-related and all-cause mortality in patients undergoing hemodialysis: The Q-Cohort Study
title_short Use of phosphate-binders and risk of infection-related and all-cause mortality in patients undergoing hemodialysis: The Q-Cohort Study
title_sort use of phosphate-binders and risk of infection-related and all-cause mortality in patients undergoing hemodialysis: the q-cohort study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065422/
https://www.ncbi.nlm.nih.gov/pubmed/30061632
http://dx.doi.org/10.1038/s41598-018-29757-0
work_keys_str_mv AT yamadashunsuke useofphosphatebindersandriskofinfectionrelatedandallcausemortalityinpatientsundergoinghemodialysistheqcohortstudy
AT tokumotomasanori useofphosphatebindersandriskofinfectionrelatedandallcausemortalityinpatientsundergoinghemodialysistheqcohortstudy
AT taniguchimasatomo useofphosphatebindersandriskofinfectionrelatedandallcausemortalityinpatientsundergoinghemodialysistheqcohortstudy
AT yoshidahisako useofphosphatebindersandriskofinfectionrelatedandallcausemortalityinpatientsundergoinghemodialysistheqcohortstudy
AT arasehokuto useofphosphatebindersandriskofinfectionrelatedandallcausemortalityinpatientsundergoinghemodialysistheqcohortstudy
AT tatsumotonarihito useofphosphatebindersandriskofinfectionrelatedandallcausemortalityinpatientsundergoinghemodialysistheqcohortstudy
AT hirakatahideki useofphosphatebindersandriskofinfectionrelatedandallcausemortalityinpatientsundergoinghemodialysistheqcohortstudy
AT kitazonotakanari useofphosphatebindersandriskofinfectionrelatedandallcausemortalityinpatientsundergoinghemodialysistheqcohortstudy
AT tsuruyakazuhiko useofphosphatebindersandriskofinfectionrelatedandallcausemortalityinpatientsundergoinghemodialysistheqcohortstudy